R Fleischmann
R Fleischmann publishes mostly in Rheumatology, Immunology and Genetics, on topics such as Rheumatoid Arthritis Research and Therapies, Chronic Lymphocytic Leukemia Research and Systemic Lupus Erythematosus Research.
- World rank
- #4,731,181 of 7,710,434 ranked researchers
- Rank in United States
- #1,244,206 of 1,627,098
- Works
- 47
- Citations
- 1.2k
- Citations per work
- 25.2
What does R Fleischmann research?
R Fleischmann's work is mostly in Medicine (61%), Immunology and Microbiology (9%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2961.2%
- Medicine2961.2%
- Everything else1429.7%
- Life Sciences49.1%
- 1Rheumatology33% of their works
- 2Immunology9% of their works
- 3Genetics8% of their works
- 4Hematology7% of their works
- 5Radiology, Nuclear Medicine and Imaging7% of their works
- 6Pathology and Forensic Medicine7% of their works
Research topics
- Rheumatoid Arthritis Research and Therapies
- Chronic Lymphocytic Leukemia Research
- Systemic Lupus Erythematosus Research
- Autoimmune and Inflammatory Disorders Research
- Lymphoma Diagnosis and Treatment
- Biosimilars and Bioanalytical Methods
- Monoclonal and Polyclonal Antibodies Research
- Peripheral Neuropathies and Disorders
Which keywords describe R Fleischmann's research?
The keywords of their largest research topics: Autoantibodies, Inflammation, Rheumatoid Arthritis, Rituximab, Chronic Lymphocytic Leukemia, Genomic Aberrations, Monoclonal Antibodies and Antiphospholipid Syndrome.
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy
- Immunogenicity
- Biosimilars
- Juvenile Idiopathic Arthritis
- Classification
- Antiphospholipid Syndrome
- Genomic Aberrations
- Rituximab
- Inflammation
- Autoantibodies
- Rheumatoid Arthritis
- Chronic Lymphocytic Leukemia
- Monoclonal Antibodies
- Systemic Lupus Erythematosus
- Hemophagocytic Lymphohistiocytosis
- Lymphoma
- Fc Receptors
- Therapeutic Antibodies
- Guillain-Barré Syndrome
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Autoantibodies352 topics
- Inflammation271 topic
- Rheumatoid Arthritis271 topic
- Rituximab162 topics
- Chronic Lymphocytic Leukemia101 topic
- Genomic Aberrations101 topic
- Monoclonal Antibodies102 topics
- Antiphospholipid Syndrome81 topic
- Systemic Lupus Erythematosus81 topic
- Classification61 topic
- Hemophagocytic Lymphohistiocytosis61 topic
- Juvenile Idiopathic Arthritis61 topic
- Lymphoma61 topic
- Biosimilars51 topic
- Fc Receptors51 topic
- Immunogenicity51 topic
- Therapeutic Antibodies51 topic
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy31 topic
- Guillain-Barré Syndrome31 topic
Where does R Fleischmann work?
R Fleischmann's main affiliation in the publication record is Metroplex Clinical Research Center, United States.
How many publications and citations does R Fleischmann have?
OpenAlex counts 47 works and 1,183 citations for R Fleischmann, an h-index of 10, ranking #4,731,181 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about R Fleischmann. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.